Rybelsus is the oral form of semaglutide, FDA-approved for type 2 diabetes (2019). Daily tablet (3 → 7 → 14 mg).

How is Rybelsus taken?

On empty stomach with ≤120 mL plain water, 30+ minutes before any other oral medication, food, or beverage.

Rybelsus — Drug Reference, Dosing, Trials

Rybelsus

Released: January 15, 2026Last reviewed: October 15, 2026

Brand name for oral semaglutide, FDA-approved for type 2 diabetes mellitus. Daily tablet (3, 7, 14 mg).

By Novo NordiskUpdated 2026-05-25

Researched By

Dr. Parmis

Medical Researcher · Western University of Health Sciences

Medically Reviewed By

Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: October 15, 2026 · This page is informational and does not constitute medical advice.

Brand name for oral semaglutide, FDA-approved for type 2 diabetes mellitus. Daily tablet (3, 7, 14 mg).

Manufacturer

Novo Nordisk

FDA status

FDA-approved